QT Imaging Completes First Routine FDA Inspection With Zero Form 483 Observations

QT Imaging (QTI) said Tuesday that the first routine inspection of its quality management system and related processes by the US Food and Drug Administration was completed with zero Form 483 observations. The FDA inspector further provided positive feedback regarding the organization of QT Imaging's QMS and the its responsiveness throughout the inspection process, according to the company.